pirinixic acid has been researched along with Heart Failure in 2 studies
pirinixic acid: structure
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaimoto, S | 1 |
Hoshino, A | 1 |
Ariyoshi, M | 1 |
Okawa, Y | 1 |
Tateishi, S | 1 |
Ono, K | 1 |
Uchihashi, M | 1 |
Fukai, K | 1 |
Iwai-Kanai, E | 1 |
Matoba, S | 1 |
Chen, R | 1 |
Liang, F | 1 |
Morimoto, S | 1 |
Li, Q | 1 |
Moriya, J | 1 |
Yamakawa, J | 1 |
Takahashi, T | 1 |
Iwai, K | 1 |
Kanda, T | 1 |
2 other studies available for pirinixic acid and Heart Failure
Article | Year |
---|---|
Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
Topics: Animals; Aorta; Blotting, Western; Disease Models, Animal; Echocardiography; Energy Metabolism; Fatt | 2017 |
The effects of a PPARalpha agonist on myocardial damage in obese diabetic mice with heart failure.
Topics: Adiponectin; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Heart Failure; Mice | 2010 |